Percutaneous Coronary Intervention Followed by Minimally Invasive Mitral Valve Surgery in Ischemic Mitral

Christos G Mihos1, Orlando Santana, Andrés M Pineda

  • 1From the *Division of Cardiology, Columbia University, Mount Sinai Heart Institute, Miami Beach, FL USA; †Columbia University Medical Center, New York, NY USA; and ‡Department of Anesthesia, Mount Sinai Medical Center, Miami Beach, FL USA.

Insights

A staged treatment for coronary artery disease and ischemic mitral regurgitation (IMR) involving percutaneous coronary intervention (PCI) followed by valve surgery shows low perioperative risk and good midterm survival.

Area of Science:

  • Cardiovascular Surgery
  • Interventional Cardiology
  • Cardiac Valve Disease

Background:

  • Optimal treatment for coronary artery disease (CAD) with severe ischemic mitral regurgitation (IMR) is debated.
  • Combined surgical revascularization and valve repair/replacement via sternotomy is standard but carries high risk.
  • A staged approach using percutaneous coronary intervention (PCI) followed by minimally invasive valve surgery may offer an alternative.

Purpose of the Study:

  • To evaluate the safety and efficacy of a staged treatment strategy for patients with CAD and severe IMR.
  • To compare this staged approach with traditional combined surgery.

Main Methods:

  • Retrospective analysis of 31 consecutive patients with CAD and severe IMR.
  • Patients underwent PCI followed by minimally invasive valve surgery between February 2009 and April 2014.
  • Data collected included demographics, procedural details, perioperative outcomes, and long-term survival.

Main Results:

  • Mean age was 72 years, LVEF 35%. STS predicted mortality was 5.1%.
  • PCI was performed first, followed by valve surgery within 36 days.
  • 30-day mortality was 3%, with low rates of acute kidney injury and no strokes. 5-year survival was 80%.

Conclusions:

  • A staged PCI and minimally invasive valve surgery approach is feasible for CAD patients with IMR.
  • This strategy demonstrates low perioperative morbidity and favorable midterm survival rates.
  • This approach may be a viable alternative to combined median sternotomy procedures.
Abstract

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
456
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
567
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
518
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
782
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
1.0K
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
1.1K